Advertisement
As HIV becomes a lifetime disease instead of a fatal disease

AACR: Cancer Burden Changing for Americans With HIV

0
AIDS-linked tumors predicted to decline by 2030
Taking antibiotics for an extended period in early to middle adulthood might increase risk for colorectal adenomas

Long-Term Antibiotic Use May Up Risk of Colorectal Adenomas

0
Medications that alter gut bacteria might set stage for polyp development, researchers say
There is variation in influenza vaccination coverage by industry and occupation

Variation in Occupational Influenza Vaccination Coverage

0
Wide variation by state in vaccination coverage among tier 1 and health care personnel groups
Maximum body mass index over 16 years of weight history is associated with increased risk of all-cause death

Maximum BMI Over 16 Years Ups Risk of All-Cause Death

0
If BMI was defined as a single measure, there was a significant inverse link for overweight, mortality
Circadian rhythms might play a role in prostate cancer development and outcomes

AACR: Shorter Sleep Duration Linked to Prostate CA Mortality

0
Findings for men younger than 65
Physicians should be aware that responding to a negative health care review could potentially expose personal medical information

Doctors Must Be Wary of HIPAA Violations With Online Reviews

0
Physicians should keep their replies to patient reviews short and simple
Many survivors of childhood cancer have mutations in cancer-associated genes

AACR: Genetic Mutations Seen in Many Childhood Cancer Survivors

0
One in four children who lived through cancer developed another cancer by age 45, researchers say
Loss of E-cadherin protein expression in the pretherapeutic biopsy of rectal cancer is associated with fewer metastases and improved survival

Protein Expression Predicts Rectal Cancer Outcomes

0
Best prognostic value from E-cadherin expression + resection growth pattern
Adding tumor-treating fields to temozolomide is associated with improved progression-free and overall survival in glioblastoma

AACR: TTFields + Temozolomide Ups Survival in Glioblastoma

0
Compliance with TTFields treatment predicts outcome, with better outcome for >18 hour/day
For patients with pretreated advanced non-small-cell lung cancer

AACR: Five-Year Survival 16 Percent With Nivolumab in NSCLC

0
Of the 16 patients who survived at least five years, nine were male, 12 were current smokers at baseline